News & Media

Newsroom

Dr. Sunita Misra, MD, PhD, Selected as a Fellow of the American Epilepsy Society for Professional Accomplishment and Deep Commitment to the Field of Epilepsy

12.02.2024

SK Life Science Presents Cenobamate Research at the 2024 American Epilepsy Society (AES) Annual Meeting

11.25.2024

SK Life Science, Inc. Announces Campaign to Support Patient Recruitment in Ongoing Global Study for Adolescents Living with Primary Generalized Tonic-Clonic (PGTC) Seizures

07.31.2024

XCOPRI® (cenobamate tablets) CV Receives FDA Approval for Alternate Methods of Administration That Include Crushed Tablet in Liquid Suspension Taken Orally or Through a Nasogastric Tube

4.11.2024

SK Life Science Announces Data Presentations for XCOPRI® (cenobamate tablets) CV at the 2024 American Academy of Neurology Annual Meeting

4.9.2024

Welcome to the news and information center for SK Life Science, Inc.

To learn more about SK Life Science, please download our corporate brochure

For more information about epilepsy, please download this infographic

For more information about Lennox-Gastaut syndrome, please download this fact sheet

X Community Guidelines

LinkedIn Community Guidelines

Bluesky Community Guidelines

Youtube Community Guidelines

Facebook Community Guidelines

SK Life Science at a Glance

Headquarters Location: Paramus, NJ

R&D Begins: 1993

Parent Company: SK Life Science is a subsidiary of SK Biopharmaceuticals, CO., LTD, and both are a part of SK Group

Number of Employees: 200+ Employees

Disease Category Focus: CNS Disorders and Oncology

Pipeline: 8 compounds under clinical development

Top